Compass Therapeutics Reports 2024 Second Quarter Financial Results and Provides Corporate Update
12 août 2024 08h00 HE
|
Compass Therapeutics
Compass Therapeutics announces 2nd quarter results and provides clinical results update
Compass Therapeutics Completes Patient Enrollment in COMPANION-002, a Randomized Study of CTX-009 in Combination with Paclitaxel, and Provides an Update on the Development Plan in Biliary Tract Cancer
06 août 2024 08h00 HE
|
Compass Therapeutics
Completed enrollment of the planned 150 patients in COMPANION-002, a Phase 2/3 trial of CTX-009 plus paclitaxel versus paclitaxel in patients with previously treated, unresectable advanced Metastatic...
[Latest] Global Bispecific Antibodies Market Size/Share Worth USD 53.8 Billion by 2033 at a 24.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
04 avr. 2024 12h30 HE
|
Custom Market Insights
Austin, TX, USA, April 04, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Bispecific Antibodies Market Size, Trends and Insights By Application (Cancer...
Tobemstomig Clinical Trials Bispecific Antibodies Market Clinical Trials Drug Sales Market Forecast 2029
17 mars 2024 13h28 HE
|
KuicK Research
Delhi, March 17, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market Opportunity Insight 2029 Report Highlights: Global Market Forecast Till 2029: > USD 36 BillionApproved Bispecific...
Plamotamab Clinical Trials Global Bispecific Antibodies Market Drug Sales Report 2029
17 mars 2024 13h23 HE
|
KuicK Research
Delhi, March 17, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market Opportunity Insight 2029 Report Highlights: Global Market Forecast Till 2029: > USD 36 BillionApproved Bispecific...
Pidilizumab Clinical Trials Bispecific Antibodies Market Report 2029
17 mars 2024 13h09 HE
|
KuicK Research
Delhi, March 17, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market Opportunity Insight 2029 Report Highlights: Global Market Forecast Till 2029: > USD 36 BillionApproved Bispecific...
Navicixizumab Clinical Trials Bispecific Antibodies Market Size Drug Sales Insight
17 mars 2024 13h08 HE
|
KuicK Research
Delhi, March 17, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market Opportunity Insight 2029 Report Highlights: Global Market Forecast Till 2029: > USD 36 BillionApproved Bispecific...
Lomvastomig Clinical Trials Bispecific Antibodies Market Clinical Pipeline Insight
17 mars 2024 12h38 HE
|
KuicK Research
Delhi, March 17, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market Opportunity Insight 2029 Report Highlights: Global Market Forecast Till 2029: > USD 36 BillionApproved Bispecific...
Imvotamab Clinical Trials Bispecific Antibodies Market Growth Outlook
17 mars 2024 12h35 HE
|
KuicK Research
Delhi, March 17, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market Opportunity Insight 2029 Report Highlights: Global Market Forecast Till 2029: > USD 36 BillionApproved Bispecific...
Acimtamig Clinical Trial Bispecific Antibodies Market Insight 2029
17 mars 2024 12h11 HE
|
KuicK Research
Delhi, March 17, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market Opportunity Insight 2029 Report Highlights: Global Market Forecast Till 2029: > USD 36 BillionApproved Bispecific...